Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

2142210 Title: ANTICORPS MONOCLONAL ANTI-LAG-3 CYTOTOXIQUE ET SON UTILISATION DANS LE TRAITEMENT OU LA PRÉVENTION D'UN REJET DU GREFFON D'ORGANE ET DE MALADIES AUTO-IMMUNES

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
087508651
WO application number:
IB2008001072
Type:
European patent granted for BE
Status:
Deemed Void
Publication number:
2142210
WO publication number:
WO2008132601
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
30/04/2008
Grant date:
24/08/2016
EP publication date:
13/01/2010
WO publication date:
06/11/2008
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
24/08/2016
EP B1 publication date:
24/08/2016
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
30/04/2028

Applicant

1

Name:
Immutep
Legal Form:
From:
24/08/2016
Address:
Parc Club Orsay 2 rue Jean Rostand, 91893 Orsay Cedex, France (FR)
To:

2

Name:
INSERM (Institut National de la Santé et de la Recherche Médicale)
Legal Form:
From:
24/08/2016
Address:
101, rue de Tolbiac, 75654 Paris Cedex 13, France (FR)
To:

Inventor

1

Name:
TRIEBEL, Frédéric
Legal Form:
Address:
F-78000 Versailles, France (FR)

2

Name:
VANHOVE, Bernard
Legal Form:
Address:
F-44400 Rezé, France (FR)

3

Name:
HAUDEBOURG, Thomas
Legal Form:
Address:
F-44000 Nantes, France (FR)

Priority

Priority patent number:
07290545
Priority date:
30/04/2007
Priority country:
European Patent Office (EPO) (EP)

Classification

IPC or IDT classification:
A61K 39/00; C07K 16/28;

Publication

European Patent Bulletin

1

Issue number:
201634
Publication date:
24/08/2016
Description:
Grant (B1)

2

Issue number:
201637
Publication date:
14/09/2016
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual fee

Annual fee(s) Due Date:
02/05/2017
Annual fee number:
10
Annual fee amount:
185 Euro
Expected payer:
Last annual fee payment date:
Last annual fee paid number:
Payer:
Filing date Document type Publication Type Document Description Number of pages File Type